CJC 1295 DAC 2 mg Peptide Sciences

How to use CJC 1295 DAC 2 mg Peptide Sciences

Athletes have been using CJC 1295 DAC 2 mg Peptide Sciences for 10 years to improve their athletic performance naturally. It is a unique peptide that stimulates processes in the body that enhance athletic performance. The active ingredient is an analogue of somatoliberin, which is secreted in the human body. The drug is injectable.

What are the effects of CJC 1295 DAC 2 mg Peptide Sciences?

Somatoliberin is a substance that stimulates the production of growth hormone (somatotropin). This hormone, in turn, has an anabolic effect. The prefix DAC means that the drug has a longer period of action than the previous version of the peptide. It lasts up to 2 weeks because it binds to plasma proteins, which prevents it from being eliminated.

CJC 1295 DAC 2 mg Peptide Sciences acts on the pituitary gland to release more growth hormones. The effect of the drug is therefore the same as that of conventional somatotropin:

• increase in muscle mass;
• elimination of the fat layer;
• increase of power indicators;
• rejuvenation, improvement of the skin;
• strengthening of bone tissue;
• strengthening of sleep.

Pumping effect appears in the course when the muscles grow in size as if swelling. These properties make the tool popular among bodybuilders who care about relief and high-quality muscle mass.

Side effects

CJC 1295 DAC 2 mg Peptide Sciences can be considered a safe drug. No serious side effects have been identified. An allergic reaction may occur at the injection site. It is manifested by itching, redness and swelling.

It is important to respect the recommended dosage. If exceeded, unpredictable side effects may develop.

Intake and dosage characteristics

Although the drug has a long half-life, the lower its concentration in the blood, the weaker the effect. That is why injections should be done twice a week. This helps to achieve the desired level of the substance throughout the course.

The dose of CJC 1295 DAC 2 mg Peptide Sciences is calculated by weight. On average, 30 mcg per 1 kg of body weight. Optimal doses are 1000 mcg twice a week. To improve the outcome of the course, sports nutrition and training are recommended.

The peptide combines well with other drugs in its group. For example, GHRP-6. This enhances the effect of the application, as the peptides reinforce each other.

Whether the course is individual or combined, it can only be taken after consultation with the doctor. The peptide is suitable for drying and mass harvesting cycles.

List of references

1. Guillaume V, Contesse V, Gray PC, Lefkowitz RJ, Teillon JP. “Distinct roles of the N-terminal and C-terminal tails in CJC-1295 analogs: studies using human GHRH-receptor-expressing cells.” Peptides. 2002;23(11):2037-2043.
2. Chan L, Smith RG. “Recombinant protein-based coupling strategies to create covalently-linked homodimeric and heterodimeric peptide hormone agonists.” Methods Mol Biol. 2008;448:159-169.
3. Teillon JP, Guillaume V, Compaore D, Piveteau C, Couvineau A, Laburthe M. “Covalent dimerization of human GHRH receptors by CJC-1295 stimulates growth hormone release in vitro and in vivo.” Peptides. 2001;22(12):2027-2034.
4. O’Hea LS, Camiña JP, Germano PM, et al. “Enhancement of the somatotroph responsiveness to growth hormone-releasing hormone after continuous administration of a GH secretagogue (hexarelin) in pigs.” J Endocrinol. 2003;177(2):261-268.
5. Tralau-Stewart CJ, Palmer J, Guncar G, et al. “Activation of growth hormone secretagogue receptors induces neuronal excitation.” Neuroendocrinology. 2003;78(5):246-257.